GABA PS
GABA PS, licence 80090529: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Botanica Research
- NPN or DIN-HM
- 80090529
- Status
- Active licence
- Licence date
- 8 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 2.0 mg | 4,000 µg |
| Withania somnifera Source : Racine Potency : 2.1 mg Withanolides | 30.0 mg | Not calculated |
| Folate Source : Acide folique | 50.0 mcg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 50.0 mg | 100,000 µg |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 100.0 mg | Not calculated |
| Thiamine Source : Thiamine | 2.0 mg | 4,000 µg |
| Calcium Source : Carbonate de calcium | 50.0 mg | 100,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Dioxyde de silicium, Stéarate de magnésium, Saveur de vanille, Carboxyméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation. Used as a sleep aid and/or helps to relieve nervousness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience diarrhea, nausea, vomiting and abdominal pain. Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use this product if you have scleroderma. Do not use if you are taking anti-cancer medications, blood thinners, antidepressant medications (e.g. selective serotonin reuptake inhibitors (SSRI)), anti-HIV agents, cardiovascular medications, immunosuppressants, and/or contraceptive medications.
Source
Official Health Canada record, licence 80090529
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.